225 related articles for article (PubMed ID: 27556794)
21. Utility of brain fluorodeoxyglucose PET in children with possible autoimmune encephalitis.
Aydos U; Arhan E; Akdemir ÜÖ; Akbaş Y; Aydin K; Atay LÖ; Serdaroğlu A
Nucl Med Commun; 2020 Aug; 41(8):800-809. PubMed ID: 32459714
[TBL] [Abstract][Full Text] [Related]
22. A follow-up ¹⁸F-FDG brain PET study in a case of Hashimoto's encephalopathy causing drug-resistant status epilepticus treated with plasmapheresis.
Pari E; Rinaldi F; Premi E; Codella M; Rao R; Paghera B; Panarotto MB; De Maria G; Padovani A
J Neurol; 2014 Apr; 261(4):663-7. PubMed ID: 24390201
[TBL] [Abstract][Full Text] [Related]
23. Interesting Manifestation of Autoimmune Encephalitis on FDG PET Scan.
Doroudinia A; Safarpour Lima B; Bakhshayesh Karam M; Ghadimi N; Yousefi F
Clin Nucl Med; 2022 Feb; 47(2):e190-e191. PubMed ID: 34392290
[TBL] [Abstract][Full Text] [Related]
24. Enhanced MRI and 18F-FDG PET/CT Findings of Primary Central Nervous System Lymphoma Mimicking Encephalitis.
Ge J; Zuo C; Guan Y; Zhao G
Clin Nucl Med; 2016 Oct; 41(10):e436-8. PubMed ID: 27355853
[TBL] [Abstract][Full Text] [Related]
25. FDG-PET findings in patients with suspected encephalitis.
Lee BY; Newberg AB; Liebeskind DS; Kung J; Alavi A
Clin Nucl Med; 2004 Oct; 29(10):620-5. PubMed ID: 15365433
[TBL] [Abstract][Full Text] [Related]
26. Cerebral (18)FluoroDeoxy-Glucose Positron Emission Tomography in paediatric anti N-methyl-D-aspartate receptor encephalitis: A case series.
Lagarde S; Lepine A; Caietta E; Pelletier F; Boucraut J; Chabrol B; Milh M; Guedj E
Brain Dev; 2016 May; 38(5):461-70. PubMed ID: 26542469
[TBL] [Abstract][Full Text] [Related]
27. Rapidly Cycling Auras and Episodic Focal Dystonia in Anti-LGI1 Autoimmune Encephalitis.
Fantaneanu TA; Bhattacharyya S; Milligan TA; Pennell PB
JAMA Neurol; 2016 Sep; 73(9):1150. PubMed ID: 27399958
[No Abstract] [Full Text] [Related]
28. Brain 18F-FDG-PET characteristics in patients with paraneoplastic neurological syndrome and its correlation with clinical and MRI findings.
Masangkay N; Basu S; Moghbel M; Kwee T; Alavi A
Nucl Med Commun; 2014 Oct; 35(10):1038-46. PubMed ID: 25023997
[TBL] [Abstract][Full Text] [Related]
29.
Liu X; Yu T; Zhao X; Li G; Lv R; Ai L; Wang Q
CNS Neurosci Ther; 2022 Feb; 28(2):269-278. PubMed ID: 34837479
[TBL] [Abstract][Full Text] [Related]
30. 18F-FDG PET/CT in anti-LGI1 encephalitis: initial and follow-up findings.
Park S; Choi H; Cheon GJ; Wook Kang K; Lee DS
Clin Nucl Med; 2015 Feb; 40(2):156-8. PubMed ID: 25140541
[TBL] [Abstract][Full Text] [Related]
31. Autoimmune encephalitis associated with vitiligo?
Haitao R; Huiqin L; Tao Q; Xunzhe Y; Xiaoqiu S; Wei L; Jiewen Z; Liying C; Hongzhi G
J Neuroimmunol; 2017 Sep; 310():14-16. PubMed ID: 28778439
[TBL] [Abstract][Full Text] [Related]
32. 18F-FDG PET/CT in Anti-NMDA Receptor Encephalitis: Typical Pattern and Follow-up.
Moubtakir A; Dejust S; Godard F; Messaoud L; Morland D
Clin Nucl Med; 2018 Jul; 43(7):520-521. PubMed ID: 29742610
[TBL] [Abstract][Full Text] [Related]
33. A novel classification model based on cerebral 18F-FDG uptake pattern facilitates the diagnosis of acute/subacute seropositive autoimmune encephalitis.
Bai S; Zhang C; Yao X; Shao H; Huang G; Liu J; Hao Y; Guan Y
J Neuroradiol; 2023 Sep; 50(5):492-501. PubMed ID: 37142216
[TBL] [Abstract][Full Text] [Related]
34. Autoimmune Encephalitis Concomitant with SARS-CoV-2 Infection: Insight from
Grimaldi S; Lagarde S; Harlé JR; Boucraut J; Guedj E
J Nucl Med; 2020 Dec; 61(12):1726-1729. PubMed ID: 32709734
[TBL] [Abstract][Full Text] [Related]
35. Autoimmune encephalitis associated with voltage-gated potassium channels-complex and leucine-rich glioma-inactivated 1 antibodies - a national cohort study.
Celicanin M; Blaabjerg M; Maersk-Moller C; Beniczky S; Marner L; Thomsen C; Bach FW; Kondziella D; Andersen H; Somnier F; Illes Z; Pinborg LH
Eur J Neurol; 2017 Aug; 24(8):999-1005. PubMed ID: 28544133
[TBL] [Abstract][Full Text] [Related]
36. 18F-FDG PET/CT and Melanoma: Value of Fourth and Subsequent Posttherapy Follow-up Scans for Patient Management.
Mena E; Taghipour M; Sheikhbahaei S; Mirpour S; Xiao J; Subramaniam RM
Clin Nucl Med; 2016 Sep; 41(9):e403-9. PubMed ID: 27355846
[TBL] [Abstract][Full Text] [Related]
37. 18F-FDG PET/CT and primary hepatic MALT: a case series.
Albano D; Giubbini R; Bertagna F
Abdom Radiol (NY); 2016 Oct; 41(10):1956-9. PubMed ID: 27259334
[TBL] [Abstract][Full Text] [Related]
38. Incidence of Brain Metastases on Follow-up
Nia ES; Garland LL; Eshghi N; Nia BB; Avery RJ; Kuo PH
J Nucl Med Technol; 2017 Sep; 45(3):193-197. PubMed ID: 28705927
[TBL] [Abstract][Full Text] [Related]
39. The role of early 18F-FDG PET/CT in therapeutic management and ongoing risk stratification of high/intermediate-risk thyroid carcinoma.
Triviño Ibáñez EM; Muros MA; Torres Vela E; Llamas Elvira JM
Endocrine; 2016 Mar; 51(3):490-8. PubMed ID: 26224589
[TBL] [Abstract][Full Text] [Related]
40. Using positron emission tomography (PET) response criteria in solid tumours (PERCIST) 1.0 for evaluation of 2'-deoxy-2'-[18F] fluoro-D-glucose-PET/CT scans to predict survival early during treatment of locally advanced non-small cell lung cancer (NSCLC).
Fledelius J; Khalil AA; Hjorthaug K; Frøkiaer J
J Med Imaging Radiat Oncol; 2016 Apr; 60(2):231-8. PubMed ID: 26678718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
